טוען...
BATCAVE: calling somatic mutations with a tumor- and site-specific prior
Detecting somatic mutations withins tumors is key to understanding treatment resistance, patient prognosis and tumor evolution. Mutations at low allelic frequency, those present in only a small portion of tumor cells, are particularly difficult to detect. Many algorithms have been developed to detec...
שמור ב:
| הוצא לאור ב: | NAR Genom Bioinform |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7003682/ https://ncbi.nlm.nih.gov/pubmed/32051931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nargab/lqaa004 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|